KHYG-1 was established 1997 from the peripheral blood of a 45-year-old woman with aggressive natural killer cell (NK) leukemia. Human natural killer cell line with a p53 point mutation as a model for p53-associated leukemogenesis and a model for differentiation of NK/T cells.